Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs

2021/02/02 by Shun Zhang, Lu Li, Jie Wang +5 · 18 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer-related molecular mechanisms research #MicroRNA in disease regulation #Cholesterol and Lipid Metabolism

paper · doi:10.1016/j.cca.2021.01.019

Cited by

• New Horizons for the Roles and Association of APE1/Ref-1 and ABCA1 in Atherosclerosis. [europepmc]
• The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway. [europepmc]
• Genetic and Epigenetic Regulation of Lipoxygenase Pathways and Reverse Cholesterol Transport in Atherogenesis. [europepmc]
• Current Options and Future Perspectives in the Treatment of Dyslipidemia. [europepmc]
• Relationship between protein arginine methyltransferase and cardiovascular disease (Review). [europepmc]
• Biomedical Advances in ABCA1 Transporter: From Bench to Bedside. [europepmc]
• Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review. [europepmc]
• Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study. [europepmc]
• The role of noncoding RNAs in metabolic reprogramming of cancer cells. [europepmc]
• Noncoding RNAs in atherosclerosis: regulation and therapeutic potential. [europepmc]
• New insights into the suppression of inflammation and lipid accumulation by JAZF1 . [europepmc]
• The lncRNA GAS5 upregulates ANXA2 to mediate the macrophage inflammatory response during atherosclerosis development. [europepmc]
• The potential of ARL4C and its-mediated genes in atherosclerosis and agent development. [europepmc]
• Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine. [europepmc]
• Unraveling LncRNA GAS5 in Atherosclerosis: Mechanistic Insights and Clinical Translation. [europepmc]
• Epigenetic‑ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review). [europepmc]
• Research Status and Latest Progress in the Regulatory Mechanisms of ABCA1. [europepmc]
• RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [europepmc]